Chemical biology and small molecule screening
4 European H2020 organizations list this as part of their work.
Most active in this area
- HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
Germany's premier infection research centre specializing in anti-infective drug discovery, vaccine development, and immune system biology across 40 EU projects.
“EU-OPENSCREEN-DRIVE (chemical biology infrastructure), MORPHEUS (bioorganic chemistry and natural products), and NovAnI (hit identification strategies).”
DE40 projects - USTAV MOLEKULARNI GENETIKY AV CR V.V.I.
Czech Academy molecular genetics institute strong in immunology, cancer research, and European bio-infrastructure networks.
“EU-OPENSCREEN-DRIVE centered on medicinal chemistry and compound screening, while SILIA applied advanced microscopy to study cilia assembly.”
CZ16 projects - FUNDACION DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRINCIPE FELIPE
Valencia-based biomedical research centre specializing in polymer nanomedicines, biomaterials for tissue regeneration, and chemical biology screening.
“Participates in EU-OPENSCREEN-DRIVE, a pan-European research infrastructure for compound screening and medicinal chemistry.”
ES7 projects - INSTYTUT BIOCHEMII I BIOFIZYKI POLSKIEJ AKADEMII NAUK
Polish Academy of Sciences institute specializing in seed biology, metabolomics, mass spectrometry imaging, and chemical biology screening infrastructure.
“Participated in EU-OPENSCREEN-DRIVE, a pan-European research infrastructure for chemical biology and compound screening.”
PL3 projects